Critical Care Assessment and Management of Acute Ischemic Stroke

Journal of Vascular and Interventional Radiology

Volumn 15, Issue 1 II, 2004, Pages

  Singh, Vineeta ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ALTEPLASE; ANCROD; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DILTIAZEM; DOPAMINE; ESMOLOL; FENTANYL; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; HEPARIN; LABETALOL; MANNITOL; METOPROLOL; MIDAZOLAM; MORPHINE; NEUROMUSCULAR BLOCKING AGENT; NICARDIPINE; NORADRENALIN; OPIATE; PENTOBARBITAL; PHENYLEPHRINE; PROPOFOL; PROUROKINASE; UNINDEXED DRUG; VECURONIUM;

ACUTE DISEASE; ACUTE KIDNEY TUBULE NECROSIS; BLOOD PRESSURE REGULATION; BRAIN EDEMA; BRAIN METABOLISM; BRAIN PERFUSION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; DECOMPRESSION SURGERY; DRUG EFFICACY; DRUG INDICATION; EMERGENCY TREATMENT; FIBRINOLYTIC THERAPY; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HUMAN; HYPERGLYCEMIA; HYPERKALEMIA; HYPERTENSION; HYPERTHERMIA; HYPERVENTILATION; HYPOTENSION; INTENSIVE CARE; INTRACRANIAL HYPERTENSION; METABOLIC DISORDER; NEUROANATOMY; NEUROPROTECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESUSCITATION; REVIEW; SERUM OSMOLALITY;

EID: 1642539071     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rvi.0000107487.61085.6b     Document Type: Review

References (42)

1. Roberts HC, Roberts TP, Smith WS, Lee TJ, Fischbein NJ, Dillon WP. Multisection dynamic CT perfusion for acute cerebral ischemia: the "toggling-table" technique. AJNR Am J Neuroradiol 2001;22:1077-1080.
2. Lansberg MG, Albers GW, Beaulieu C, Marks MP. Comparison of diffusion-weighted MRI and CT in acute stroke. Neurology 2000; 54:1557-1561.
3. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333:1581-1587.
4. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II Study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999; 282:2003-2011.
5. Sherman DG, Atkinson RP, Chippendale T, et al. Intravenous ancrod for treatment of acute ischemic stroke. The STAT study: a randomized controlled trial. Stroke Treatment with Ancrod Trial. JAMA 2000; 283:2395-2403.
6. Albers GW, Easton JD, Sacco RL, Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke. Chest 1998; 114(suppl 5):683S-698S.
7. Adams HP Jr, Brott TG, Furlan AJ, et al. Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke - a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Circulation 1996; 94:1167-1174.
8. The Abciximab in Ischemic Stroke Investigators. Abciximab in acute ischemic stroke: a randomized, double-blind, placebo-controlled, dose-escalation study. Stroke 2000; 31:601-609.
9. Ropper AH, Shafran B. Brain edema after stroke: clinical syndrome and intracranial pressure. Arch Neurol 1984; 41:26-29.
10. Hacke W, Schwab S, Horn M, Spranger M, De Georgia M, von Kummer R. 'Malignant' middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol 1996; 53:309-315.
11. Rieke K, Schwab S, Krieger D, et al. Decompressive surgery in space-occupying hemispheric infarction: results of an open, prospective trial. Crit Care Med 1995; 23:1576-1587.
12. Frank JI. Large hemispheric infarction, deterioration, and intracranial pressure. Neurology 1995; 45:1286-1290.
13. Inao S, Kuchiwaki H, Wachi A, et al. Effect of mannitol on intracranial pressure-volume status and cerebral haemodynamics in brain oedema. Acta Neurochir Suppl 1990; 51:401-403.
14. Jafar JJ, Johns LM, Mullan SF. The effect of mannitol on cerebral blood flow. J Neurosurg 1986; 64:754-759.
15. Kaufmann AM, Cardoso ER. Aggravation of vasogenic cerebral edema by multiple-dose mannitol. J Neurosurg 1992; 77:584-589.
16. Fishman RA. Cerebrospinal Fluid in Diseases of the Nervous System. Philidelphia, PA: W.B. Saunders, 1980; 19-62,93.
17. Lassen NA. Control of cerebral circulation in health and disease. Circulation Res 1974; 34:749-760.
18. Muizelaar JP, Marmarou A, Ward JD, et al. Adverse effects of prolonged hyperventilation in patients with se-I P vere head injury: a randomized clinical trial. J Neurosurg 1991; 75:731-739.
19. Hoff JT. Cerebral protection. J Neurosurg 1986; 65:579-591.
20. Lafferty JJ, Keykhah MM, Shapiro HM, Van Horn K, Behar MG. Cerebral hypometabolism obtained with deep pentobarbital anesthesia and hypothermia (30°C). Anesthesiology 1978; 49:159-164.
21. Marshall LF, Shapiro HM, Rauscher A, Kaufman NM. Pentobarbital therapy for intracranial hypertension in metabolic coma: Reye's syndrome. Crit Care Med 1978; 6:1-5.
22. Rea GL, Rockswold GL. Barbiturate therapy in uncontrolled intracranial hypertension. Neurosurgery 1983; 12:401-404.
23. Schwab S, Steiner T, Aschoff A, et al. Early hemicraniectomy in patients with complete middle cerebral artery infarction. Stroke 1998; 29:1888-1893.
24. Britton M, Carlsson A, de Faire U. Blood pressure course in patients with acute stroke and matched controls. Stroke 1986; 17:861-864.
25. Carlberg B, Asplund K, Hagg E. Factors influencing admission blood pressure levels in patients with acute stroke. Stroke 1991; 22:527-530.
26. Wallace JD, Levy LL. Blood pressure after stroke. JAMA 1981; 246:2177-2180.
27. Ahmed N, Nasman P, Wahlgren NG. Effect of intravenous nimodipine on blood pressure and outcome after acute stroke. Stroke 2000; 31:1250-1255.
28. Adams HP Jr, Brott TG, Crowell RM, et al. Guidelines for the management of patients with acute ischemic stroke: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1994; 25:1901-1914.
29. Rordorf G, Cramer SC, Efird JT, Schwamm LH, Buonanno F, Koroshetz WJ. Pharmacological elevation of blood pressure in acute stroke: clinical effects and safety. Stroke 1997; 28:2133-2138.
30. Nedergaard M. Transient focal ischemia in hyperglycemic rats is associated with increased cerebral infarction. Brain Res 1987; 408:79-85.
31. Warner DS, Gionet TX, Todd MM, McAllister AM. Insulin-induced normoglycemia improves ischemic outcome in hyperglycemic rats. Stroke 1992; 23:1775-1780; discussion, 1781.
32. Kiers L, Davis SM, Larkins R, et al. Stroke topography and outcome in relation to hyperglycaemia and diabetes. J Neurol Neurosurg Psychiatry 1992; 55:263-270.
33. Weir CJ, Murray GD, Dyker AG, Lees KR. Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow-up study. BMJ 1997; 314:1303-1306.
34. Reith J, Jorgensen HS, Pedersen PM, et al. Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome. Lancet 1996; 347:422-425.
35. Kammersgaard LP, Rasmussen BH, Jorgensen HS, Reith J, Weber U, Olsen TS. Feasibility and safety of inducing modest hypothermia in awake patients with acute stroke through surface cooling: a case-control study-the Copenhagen Stroke Study. Stroke 2000; 31:2251-2256.
36. Marion DW, Penrod LE, Kelsey SF, et al. Treatment of traumatic brain injury with moderate hypothermia. N Engl J Med 1997; 336:540-546.
37. Schwab S, Schwarz S, Spranger M, Keller E, Bertram M, Hacke W. Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction. Stroke 1998; 29:2461-2466.
38. Bradford A, Lees K. Design of the Intravenous Magnesium Efficacy in Acute Stroke (IMAGES) Trial. Curr Control Trials Cardiovasc Med 2000; 1:184-190.
39. DeGraba TJ, Pettigrew LC. Why do neuroprotective drugs work in animals but not humans? Neurol Clin 2000; 18:475-493.
40. Koh MG, Phan TG, Atkinson JL, Wijdicks EF. Neuroimaging in deteriorating patients with cerebellar infarcts and mass effect. Stroke 2000; 31:2062-2067.
41. Steinke W, Ley SC. Lacunar stroke is the major cause of progressive motor deficits. Stroke 2002; 33:1510-1516.
42. Mohr JP, Caplan LR, Melski JW, et al. The Harvard Cooperative Stroke Registry: a prospective registry. Neurology 1978; 28:754-762.